Varsetatug
Varsetatug is a humanized IgG1κ monoclonal antibody inhibitor targeting EpCAM/TROP1/CD326. Varsetatug has an antitumor activity. Varsetatug can be used for cancers such as breast, prostate and ovarian cancer research[1][2].
Product Specifications
CAS Number
[3036004-28-8]
Product Name Alternative
CX-2051 antibody
UNSPSC
12352100
Target
Transmembrane Glycoprotein
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
97
References & Citations
[1]Internacionales D C. International Nonproprietary Names for Pharmaceutical Substances (INN) [J]. WHO Drug Information, 2025, 39 (2) .|[2]Baeuerle PA, et al. EpCAM (CD326) finding its role in cancer. Br J Cancer. 2007 Feb 12;96 (3) :417-23. doi: 10.1038/sj.bjc.6603494. Epub 2007 Jan 9. Erratum in: Br J Cancer. 2007 May 7;96 (9) :1491.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7014265-01 0.02 mg
Recombinant Human Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 (ENPP7)
Ask
View Details 
MBS7014265-02 0.1 mg
Recombinant Human Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 (ENPP7)
Ask
View Details 
MBS7014265-03 5x 0.1 mg
Recombinant Human Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 (ENPP7)
Ask
View Details